← All Investors
QUOIN PHARMACEUTICALS LTD
QNRX
Holders
2
Combined Value
$717K
Combined Shares
108,766
Current Price
$4.62
52W High
$41.80
vs 52W High
−88.9%
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Israel Englander - Millennium Management | $503K | 0.00% | ~$14.28 | −67.7% | Bought Q1 2026 | Q1 2026 |
| Ken Griffin - Citadel Advisors | $214K | 0.00% | ~$6.60 | −30.0% | Bought Q1 2026 | Q1 2026 |
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q1 2026 | Ken Griffin - Citadel Advisors | NEW BUY | +$214K | ~$6.60 |
| Q1 2026 | Israel Englander - Millennium Management | BUY | +$9.4K | ~$6.60 |
| Q4 2025 | Israel Englander - Millennium Management | NEW BUY | +$1.1M | ~$14.43 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 2 | 108,766 | +45.4% | $717K | $6.60 |
| Q4 2025 | 1 | 74,817 | — | $1.1M | $14.43 |